Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 56 | 2023 | 2149 | 3.160 |
Why?
|
Infectious Disease Transmission, Vertical | 29 | 2021 | 1351 | 1.950 |
Why?
|
HIV Infections | 45 | 2021 | 17337 | 1.110 |
Why?
|
Antiretroviral Therapy, Highly Active | 7 | 2015 | 1894 | 0.920 |
Why?
|
HIV Protease Inhibitors | 6 | 2010 | 432 | 0.870 |
Why?
|
HIV-1 | 24 | 2016 | 6858 | 0.830 |
Why?
|
Anti-HIV Agents | 16 | 2021 | 4524 | 0.820 |
Why?
|
Cesarean Section | 10 | 2018 | 1396 | 0.810 |
Why?
|
Cesarean Section, Repeat | 1 | 2018 | 28 | 0.610 |
Why?
|
Viral Load | 7 | 2021 | 3325 | 0.590 |
Why?
|
Pregnancy | 77 | 2023 | 29868 | 0.580 |
Why?
|
Delivery, Obstetric | 9 | 2018 | 939 | 0.450 |
Why?
|
Nevirapine | 3 | 2010 | 273 | 0.410 |
Why?
|
Pregnancy Outcome | 9 | 2017 | 2921 | 0.410 |
Why?
|
Prenatal Care | 6 | 2019 | 1140 | 0.370 |
Why?
|
Bacteremia | 5 | 2019 | 977 | 0.360 |
Why?
|
Peripartum Period | 4 | 2019 | 137 | 0.340 |
Why?
|
RNA, Viral | 8 | 2015 | 2838 | 0.330 |
Why?
|
Puerperal Disorders | 5 | 2019 | 300 | 0.320 |
Why?
|
Nelfinavir | 2 | 2010 | 68 | 0.320 |
Why?
|
Hepatitis B, Chronic | 3 | 2019 | 410 | 0.310 |
Why?
|
Chemoprevention | 1 | 2010 | 325 | 0.290 |
Why?
|
Lamivudine | 2 | 2010 | 366 | 0.280 |
Why?
|
Indinavir | 1 | 2006 | 73 | 0.280 |
Why?
|
Therapeutic Human Experimentation | 1 | 2007 | 43 | 0.280 |
Why?
|
Vagina | 8 | 2004 | 841 | 0.270 |
Why?
|
Drug Resistance, Viral | 2 | 2010 | 861 | 0.260 |
Why?
|
Ritonavir | 2 | 2023 | 329 | 0.250 |
Why?
|
Fever | 3 | 2019 | 1618 | 0.250 |
Why?
|
Antibiotic Prophylaxis | 1 | 2010 | 637 | 0.250 |
Why?
|
Zidovudine | 6 | 2010 | 624 | 0.250 |
Why?
|
Hepatitis, Viral, Human | 1 | 2005 | 141 | 0.250 |
Why?
|
Obstetric Labor, Premature | 2 | 2004 | 272 | 0.240 |
Why?
|
Acyclovir | 1 | 2005 | 267 | 0.240 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 621 | 0.230 |
Why?
|
Lactams | 1 | 2023 | 156 | 0.210 |
Why?
|
Genitalia, Female | 2 | 2003 | 147 | 0.210 |
Why?
|
Puerperal Infection | 4 | 2017 | 44 | 0.210 |
Why?
|
Herpes Simplex | 1 | 2005 | 465 | 0.200 |
Why?
|
Leucine | 1 | 2023 | 548 | 0.200 |
Why?
|
Antiviral Agents | 2 | 2023 | 3039 | 0.200 |
Why?
|
Infant, Newborn | 27 | 2021 | 26180 | 0.200 |
Why?
|
Proline | 1 | 2023 | 455 | 0.200 |
Why?
|
Obstetric Labor Complications | 2 | 2017 | 236 | 0.180 |
Why?
|
Pregnancy Trimester, Third | 4 | 2015 | 582 | 0.180 |
Why?
|
Female | 86 | 2023 | 392148 | 0.180 |
Why?
|
Multivariate Analysis | 9 | 2018 | 12043 | 0.170 |
Why?
|
Premature Birth | 4 | 2021 | 1782 | 0.170 |
Why?
|
Fetal Membranes, Premature Rupture | 3 | 1996 | 137 | 0.160 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 29 | 0.160 |
Why?
|
Pregnancy in Diabetics | 2 | 2017 | 197 | 0.160 |
Why?
|
Vaginosis, Bacterial | 3 | 2004 | 151 | 0.150 |
Why?
|
Nitriles | 1 | 2023 | 971 | 0.150 |
Why?
|
Labor, Obstetric | 2 | 2021 | 323 | 0.150 |
Why?
|
Research | 1 | 2007 | 1977 | 0.150 |
Why?
|
Uterine Diseases | 1 | 2019 | 108 | 0.150 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 2004 | 2197 | 0.140 |
Why?
|
Adult | 55 | 2019 | 220969 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 9 | 2010 | 2567 | 0.140 |
Why?
|
Streptococcus agalactiae | 2 | 2013 | 337 | 0.140 |
Why?
|
Cervix Uteri | 4 | 2004 | 570 | 0.140 |
Why?
|
Preconception Care | 1 | 2017 | 141 | 0.130 |
Why?
|
Cohort Studies | 23 | 2019 | 41457 | 0.130 |
Why?
|
Humans | 86 | 2023 | 760617 | 0.120 |
Why?
|
Patient Selection | 1 | 2007 | 4237 | 0.120 |
Why?
|
Respiratory Rate | 1 | 2015 | 175 | 0.120 |
Why?
|
Streptococcal Infections | 2 | 2013 | 617 | 0.110 |
Why?
|
Postpartum Period | 4 | 2016 | 1178 | 0.110 |
Why?
|
Respiratory Distress Syndrome, Newborn | 2 | 2010 | 233 | 0.110 |
Why?
|
Infant, Premature | 7 | 2005 | 2107 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2018 | 1185 | 0.110 |
Why?
|
Accreditation | 1 | 2016 | 473 | 0.110 |
Why?
|
Bacteria | 2 | 2004 | 2192 | 0.100 |
Why?
|
Angiomatosis, Bacillary | 1 | 1992 | 4 | 0.100 |
Why?
|
Interleukin-1 | 3 | 2004 | 1248 | 0.100 |
Why?
|
Postnatal Care | 1 | 2014 | 260 | 0.100 |
Why?
|
Virus Shedding | 3 | 2003 | 109 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2006 | 662 | 0.100 |
Why?
|
Anti-Retroviral Agents | 3 | 2010 | 1782 | 0.100 |
Why?
|
Pregnant Women | 2 | 2021 | 567 | 0.100 |
Why?
|
Clinical Competence | 2 | 2018 | 4789 | 0.100 |
Why?
|
Parity | 1 | 2015 | 924 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1048 | 0.090 |
Why?
|
Risk Factors | 21 | 2017 | 74115 | 0.090 |
Why?
|
Pregnancy Complications | 2 | 2005 | 2948 | 0.090 |
Why?
|
Regression Analysis | 4 | 2010 | 6338 | 0.090 |
Why?
|
Azithromycin | 1 | 2011 | 199 | 0.090 |
Why?
|
Gynecology | 1 | 2016 | 526 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 913 | 0.090 |
Why?
|
Anti-Bacterial Agents | 4 | 2021 | 7402 | 0.080 |
Why?
|
Logistic Models | 8 | 2017 | 13245 | 0.080 |
Why?
|
Gestational Age | 5 | 2011 | 3577 | 0.080 |
Why?
|
Obstetrics | 1 | 2016 | 666 | 0.080 |
Why?
|
Contraceptives, Oral | 1 | 2011 | 553 | 0.080 |
Why?
|
Pregnancy Trimester, Second | 3 | 2007 | 730 | 0.080 |
Why?
|
Cefazolin | 2 | 1988 | 94 | 0.080 |
Why?
|
Decision Trees | 2 | 2019 | 504 | 0.070 |
Why?
|
Medication Adherence | 2 | 2021 | 2174 | 0.070 |
Why?
|
United States | 10 | 2021 | 72272 | 0.070 |
Why?
|
Infant, Low Birth Weight | 4 | 2002 | 869 | 0.070 |
Why?
|
Surgical Wound Infection | 3 | 2010 | 1529 | 0.070 |
Why?
|
Prospective Studies | 18 | 2016 | 54360 | 0.070 |
Why?
|
Massachusetts | 6 | 2018 | 8833 | 0.070 |
Why?
|
Educational Status | 1 | 2015 | 2509 | 0.070 |
Why?
|
Drug Therapy, Combination | 4 | 2010 | 6305 | 0.070 |
Why?
|
Herpes Genitalis | 1 | 2008 | 149 | 0.070 |
Why?
|
Hemostasis, Surgical | 1 | 2007 | 126 | 0.070 |
Why?
|
Herpesvirus 2, Human | 1 | 2008 | 191 | 0.070 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2006 | 114 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2017 | 1937 | 0.070 |
Why?
|
Moxalactam | 1 | 1985 | 9 | 0.070 |
Why?
|
Insurance, Health | 1 | 2017 | 2495 | 0.060 |
Why?
|
Smoking | 4 | 2006 | 9050 | 0.060 |
Why?
|
Odds Ratio | 5 | 2017 | 9643 | 0.060 |
Why?
|
Hysterectomy | 3 | 1988 | 856 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 3194 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 4366 | 0.060 |
Why?
|
Maternal-Fetal Exchange | 1 | 2006 | 461 | 0.060 |
Why?
|
DNA, Viral | 4 | 2006 | 2195 | 0.060 |
Why?
|
HIV | 2 | 2021 | 1579 | 0.060 |
Why?
|
Prevalence | 6 | 2019 | 15689 | 0.060 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2007 | 339 | 0.060 |
Why?
|
Pyrimidinones | 1 | 2006 | 385 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4180 | 0.060 |
Why?
|
Young Adult | 7 | 2019 | 59179 | 0.060 |
Why?
|
Health Education | 1 | 1990 | 1049 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4007 | 0.060 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 262 | 0.050 |
Why?
|
Ampicillin | 2 | 2001 | 136 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2004 | 315 | 0.050 |
Why?
|
HIV Seropositivity | 3 | 2004 | 959 | 0.050 |
Why?
|
Liver Failure | 1 | 2005 | 250 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1997 | 4571 | 0.050 |
Why?
|
Area Under Curve | 3 | 2015 | 1635 | 0.050 |
Why?
|
Time Factors | 6 | 2016 | 39913 | 0.050 |
Why?
|
Case-Control Studies | 8 | 2017 | 22148 | 0.050 |
Why?
|
Apgar Score | 1 | 2002 | 126 | 0.050 |
Why?
|
Simplexvirus | 1 | 2005 | 802 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3351 | 0.050 |
Why?
|
Adolescent | 9 | 2015 | 88234 | 0.050 |
Why?
|
Body Weight | 1 | 2011 | 4614 | 0.050 |
Why?
|
Pelvic Inflammatory Disease | 2 | 1994 | 96 | 0.040 |
Why?
|
Liver | 2 | 2006 | 7512 | 0.040 |
Why?
|
Fetal Death | 1 | 2002 | 435 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2006 | 1117 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4583 | 0.040 |
Why?
|
Radiography, Interventional | 1 | 2007 | 1120 | 0.040 |
Why?
|
Retrospective Studies | 10 | 2023 | 80566 | 0.040 |
Why?
|
Infant | 6 | 2021 | 36152 | 0.040 |
Why?
|
Endometritis | 3 | 1996 | 49 | 0.040 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 24 | 0.040 |
Why?
|
Gene Products, env | 1 | 2000 | 250 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10760 | 0.040 |
Why?
|
HIV Wasting Syndrome | 1 | 1998 | 99 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2004 | 1550 | 0.040 |
Why?
|
Infection Control | 1 | 1985 | 982 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2005 | 6224 | 0.040 |
Why?
|
Meconium Aspiration Syndrome | 1 | 1997 | 30 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1182 | 0.040 |
Why?
|
Mass Screening | 2 | 1990 | 5424 | 0.040 |
Why?
|
Premedication | 3 | 1988 | 245 | 0.040 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 1997 | 25 | 0.040 |
Why?
|
Age Factors | 4 | 2019 | 18381 | 0.030 |
Why?
|
Risk Assessment | 5 | 2010 | 23972 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5878 | 0.030 |
Why?
|
Risk | 3 | 2006 | 9604 | 0.030 |
Why?
|
New York | 1 | 1998 | 874 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2011 | 1540 | 0.030 |
Why?
|
Semen | 1 | 1998 | 347 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2802 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 293 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 1997 | 778 | 0.030 |
Why?
|
Reproductive History | 1 | 1996 | 210 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2015 | 397 | 0.030 |
Why?
|
Competency-Based Education | 1 | 2016 | 222 | 0.030 |
Why?
|
Women's Health | 1 | 2004 | 2065 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2006 | 1611 | 0.030 |
Why?
|
Maternal Age | 1 | 2017 | 809 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 14648 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 564 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4242 | 0.030 |
Why?
|
Candida albicans | 1 | 1997 | 372 | 0.030 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 1997 | 326 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3688 | 0.030 |
Why?
|
Biopsy | 1 | 2005 | 6762 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2018 | 3599 | 0.030 |
Why?
|
Vaginal Smears | 3 | 2004 | 499 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 1998 | 1077 | 0.030 |
Why?
|
Homosexuality | 1 | 1993 | 267 | 0.030 |
Why?
|
Hepatitis B | 1 | 2018 | 702 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7960 | 0.030 |
Why?
|
Pregnancy, Tubal | 1 | 1992 | 15 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2017 | 3415 | 0.020 |
Why?
|
HIV Antibodies | 2 | 1998 | 1302 | 0.020 |
Why?
|
Cefoxitin | 2 | 1994 | 35 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 1996 | 529 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12966 | 0.020 |
Why?
|
Counseling | 2 | 1990 | 1538 | 0.020 |
Why?
|
Birth Weight | 1 | 1999 | 2101 | 0.020 |
Why?
|
Voluntary Programs | 1 | 1990 | 48 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 928 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1995 | 914 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7389 | 0.020 |
Why?
|
Chlamydia trachomatis | 1 | 1992 | 239 | 0.020 |
Why?
|
Thrombophlebitis | 2 | 1996 | 289 | 0.020 |
Why?
|
Educational Measurement | 1 | 2016 | 1252 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1438 | 0.020 |
Why?
|
Cefamandole | 1 | 1988 | 9 | 0.020 |
Why?
|
Chlamydia Infections | 1 | 1992 | 365 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5073 | 0.020 |
Why?
|
Hysterectomy, Vaginal | 1 | 1988 | 28 | 0.020 |
Why?
|
Tablets | 1 | 2008 | 148 | 0.020 |
Why?
|
Gastroenterology | 1 | 2014 | 577 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5491 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2016 | 1204 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2486 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3575 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2023 | 64568 | 0.020 |
Why?
|
Testosterone | 1 | 1998 | 2472 | 0.020 |
Why?
|
Probability | 2 | 2004 | 2475 | 0.020 |
Why?
|
Incidence | 3 | 2019 | 21337 | 0.020 |
Why?
|
Fallopian Tubes | 1 | 1988 | 178 | 0.020 |
Why?
|
Mezlocillin | 1 | 1986 | 3 | 0.020 |
Why?
|
Neutrophils | 2 | 2015 | 3763 | 0.020 |
Why?
|
Actinomycosis | 1 | 1986 | 19 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1999 | 2020 | 0.020 |
Why?
|
Models, Biological | 1 | 2003 | 9461 | 0.020 |
Why?
|
Mutation | 2 | 2010 | 30016 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2004 | 10175 | 0.020 |
Why?
|
Pneumonia | 1 | 1997 | 2143 | 0.020 |
Why?
|
Perinatal Care | 1 | 2008 | 244 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1997 | 2518 | 0.020 |
Why?
|
Male | 6 | 2016 | 360358 | 0.010 |
Why?
|
Genetic Variation | 1 | 2000 | 6561 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3800 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39063 | 0.010 |
Why?
|
Pelvic Neoplasms | 1 | 1986 | 247 | 0.010 |
Why?
|
Random Allocation | 2 | 1986 | 2392 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2756 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2371 | 0.010 |
Why?
|
Uterus | 1 | 1988 | 649 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3410 | 0.010 |
Why?
|
Gravidity | 1 | 2003 | 50 | 0.010 |
Why?
|
Uterine Hemorrhage | 2 | 1998 | 240 | 0.010 |
Why?
|
Pregnancy Trimesters | 1 | 2004 | 197 | 0.010 |
Why?
|
Enterobacteriaceae Infections | 1 | 1985 | 188 | 0.010 |
Why?
|
Guanine | 1 | 2004 | 278 | 0.010 |
Why?
|
Postpartum Hemorrhage | 1 | 2007 | 272 | 0.010 |
Why?
|
Poisson Distribution | 1 | 2004 | 504 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2004 | 299 | 0.010 |
Why?
|
Cytokines | 1 | 1998 | 7373 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6074 | 0.010 |
Why?
|
Genotype | 2 | 2010 | 12978 | 0.010 |
Why?
|
Curriculum | 1 | 2016 | 3738 | 0.010 |
Why?
|
Quality of Life | 2 | 2021 | 13347 | 0.010 |
Why?
|
Urinary Tract Infections | 2 | 1986 | 802 | 0.010 |
Why?
|
Tuberculosis | 1 | 1995 | 2015 | 0.010 |
Why?
|
Ethics, Medical | 1 | 1987 | 783 | 0.010 |
Why?
|
Ampicillin Resistance | 1 | 2001 | 10 | 0.010 |
Why?
|
Reference Values | 2 | 2001 | 4919 | 0.010 |
Why?
|
Introns | 1 | 2004 | 968 | 0.010 |
Why?
|
Depression | 1 | 2021 | 8132 | 0.010 |
Why?
|
Catheterization | 1 | 2007 | 1428 | 0.010 |
Why?
|
Extraction, Obstetrical | 1 | 2001 | 27 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 575 | 0.010 |
Why?
|
Survival Analysis | 2 | 2004 | 10073 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 578 | 0.010 |
Why?
|
Parturition | 1 | 2005 | 447 | 0.010 |
Why?
|
Disease Progression | 2 | 2009 | 13495 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26049 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20074 | 0.010 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 2000 | 46 | 0.010 |
Why?
|
Fetal Blood | 1 | 2006 | 1347 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15251 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1998 | 114 | 0.010 |
Why?
|
Adenine | 1 | 2004 | 985 | 0.010 |
Why?
|
Ovary | 1 | 1983 | 959 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2849 | 0.010 |
Why?
|
Proviruses | 1 | 2000 | 313 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1986 | 1389 | 0.010 |
Why?
|
Oropharynx | 1 | 1998 | 138 | 0.010 |
Why?
|
Patient Compliance | 1 | 2008 | 2688 | 0.010 |
Why?
|
Primary Health Care | 1 | 2014 | 4668 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1998 | 158 | 0.010 |
Why?
|
Herpesviridae Infections | 1 | 1998 | 269 | 0.010 |
Why?
|
Urine | 1 | 1998 | 362 | 0.010 |
Why?
|
Menstruation | 1 | 1998 | 306 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 1998 | 712 | 0.010 |
Why?
|
Mothers | 1 | 2007 | 2194 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 2001 | 589 | 0.010 |
Why?
|
Infant, Small for Gestational Age | 1 | 1999 | 462 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 1987 | 2641 | 0.010 |
Why?
|
Morbidity | 1 | 2001 | 1750 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2001 | 1936 | 0.010 |
Why?
|
Infant, Very Low Birth Weight | 1 | 1997 | 407 | 0.010 |
Why?
|
Sulbactam | 1 | 1994 | 31 | 0.010 |
Why?
|
Double-Blind Method | 2 | 1986 | 12334 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1995 | 206 | 0.010 |
Why?
|
Age of Onset | 1 | 2001 | 3302 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1998 | 749 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1998 | 1597 | 0.010 |
Why?
|
Placebos | 1 | 1998 | 1667 | 0.010 |
Why?
|
Clindamycin | 1 | 1994 | 139 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2004 | 5863 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12142 | 0.010 |
Why?
|
Gentamicins | 1 | 1994 | 243 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10505 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 1990 | 5430 | 0.010 |
Why?
|
Middle Aged | 5 | 2011 | 220584 | 0.010 |
Why?
|
Doxycycline | 1 | 1994 | 344 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 1992 | 289 | 0.010 |
Why?
|
Physical Examination | 1 | 1996 | 1254 | 0.010 |
Why?
|
Nutritional Status | 1 | 1998 | 1596 | 0.010 |
Why?
|
Leukocytes | 1 | 1998 | 2023 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1985 | 7995 | 0.010 |
Why?
|
Body Composition | 1 | 1998 | 2426 | 0.000 |
Why?
|
Sexual Partners | 1 | 1993 | 800 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2003 | 12447 | 0.000 |
Why?
|
Chorioamnionitis | 1 | 1989 | 156 | 0.000 |
Why?
|
Weight Gain | 1 | 1998 | 2350 | 0.000 |
Why?
|
Risk-Taking | 1 | 1993 | 1037 | 0.000 |
Why?
|
Labor Stage, Second | 1 | 1987 | 38 | 0.000 |
Why?
|
Length of Stay | 1 | 2001 | 6418 | 0.000 |
Why?
|
Myometrium | 1 | 1988 | 174 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 2003 | 14591 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1988 | 555 | 0.000 |
Why?
|
Labor, Induced | 1 | 1987 | 151 | 0.000 |
Why?
|
Barium Sulfate | 1 | 1986 | 180 | 0.000 |
Why?
|
Enema | 1 | 1986 | 141 | 0.000 |
Why?
|
Multicenter Studies as Topic | 1 | 1990 | 1700 | 0.000 |
Why?
|
Endometrium | 1 | 1988 | 403 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2004 | 15908 | 0.000 |
Why?
|
Pilot Projects | 1 | 1998 | 8618 | 0.000 |
Why?
|
Medical Records | 1 | 1990 | 1407 | 0.000 |
Why?
|
Infant Mortality | 1 | 1989 | 751 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1986 | 15612 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1988 | 2261 | 0.000 |
Why?
|
Confidentiality | 1 | 1987 | 608 | 0.000 |
Why?
|
Sepsis | 1 | 1996 | 2585 | 0.000 |
Why?
|
Hospitalization | 1 | 2001 | 10704 | 0.000 |
Why?
|
Informed Consent | 1 | 1987 | 1007 | 0.000 |
Why?
|
Sexual Behavior | 1 | 1990 | 2187 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1983 | 20556 | 0.000 |
Why?
|
Aged | 1 | 1985 | 169042 | 0.000 |
Why?
|